CD4 cell levels during treatment for tuberculosis (TB) in Ethiopian adults and clinical markers associated with CD4 lymphocytopenia

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Skogmar, Sten ^a   Schön, Thomas ^b,c   Balcha, Taye Tolera ^a,d   Jemal, Zelalem Habtamu ^e   Tibesso, Gudeta ^f   Björk, Jonas ^g   Björkman, Per ^a  

^a LUND UNIVERSITY   (Sweden)

^b LINKÖPING UNIVERSITY   (Sweden)

^c KALMAR COUNTY HOSPITAL   (Sweden)

^d FEDERAL MINISTRY OF HEALTH   (Ethiopia)

^e Oromia Regional Health Bureau   (Ethiopia)

^f Department of Medicine   (Ethiopia)

^g LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN;

ADULT; ARM CIRCUMFERENCE; ARTICLE; CD4 LYMPHOCYTE COUNT; CELL LEVEL; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; ETHIOPIAN; ETHNIC GROUP; EVOLUTION; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMOBILITY; LUNG TUBERCULOSIS; LYMPHOCYTOPENIA; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; PROSPECTIVE STUDY; SPUTUM SMEAR; TUBERCULOSIS CONTROL; WASTING SYNDROME;

ADULT; ANTITUBERCULAR AGENTS; BIOLOGICAL MARKERS; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; COHORT STUDIES; COINFECTION; ETHIOPIA; FEMALE; HIV INFECTIONS; HUMANS; LYMPHOPENIA; MALE; TUBERCULOSIS; YOUNG ADULT;

EID: 84892743167     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0083270     Document Type: Article

References (30)

1. WHO (2012) Global tuberculosis report 2012. Geneva, Switzerland: World Health Organization.
2. Abdool Karim SS, Naidoo K, Grobler A, Padayatchi N, Baxter C, et al. (2010) Timing of initiation of antiretroviral drugs during tuberculosis therapy. N Engl J Med 362: 697-706.
3. Blanc F-X, Sok T, Laureillard D, Borand L, Rekacewicz C, et al. (2011) Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis. N Engl J Med 365: 1471-1481.
4. Havlir D V, Kendall M a, Ive P, Kumwenda J, Swindells S, et al. (2011) Timing of antiretroviral therapy for HIV-1 infection and tuberculosis. N Engl J Med 365: 1482-1491.
5. WHO (2012) WHO policy on collaborative TB/HIV activities: guidelines for national programmes and other stakeholders. Geneva, Switzerland: World Health Organization.
6. Begtrup K, Melbye M, Biggar RJ, Goedert JJ, Knudsen K, et al. (1997) Progression to acquired immunodeficiency syndrome is influenced by CD4 T-lymphocyte count and time since seroconversion. Am J Epidemiol 145: 629-635.
7. Walker U a, Warnatz K (2006) Idiopathic CD4 lymphocytopenia. Curr Opin Rheumatol 18: 389-395.
8. Abuye C, Tsegaye A, West CE, Versloot P, Sanders EJ, et al. (2005) Determinants of CD4 counts among HIV-negative Ethiopians: role of body mass index, gender, cigarette smoking, khat (Catha Edulis) chewing, and possibly altitude? J Clin Immunol 25: 127-133.
9. Wolday D, Tsegaye A, Messele T (2002) Low absolute CD4 counts in Ethiopians. Ethiop Med J 40 Suppl 1: 11-16.
10. Jones BE, Oo MM, Taikwel EK, Qian D, Kumar a, et al. (1997) CD4 cell counts in human immunodeficiency virus-negative patients with tuberculosis. Clin Infect Dis 24: 988-991.
11. Kony SJ, Hane a a, Larouzé B, Samb a, Cissoko S, et al. (2000) Tuberculosis-associated severe CD4+ T-lymphocytopenia in HIV-seronegative patients from Dakar. SIDAK Research Group. J Infect 41: 167-171.
12. Andersen AB, Range NS, Changalucha J, Praygod G, Kidola J, et al. (2012) CD4 lymphocyte dynamics in Tanzanian pulmonary tuberculosis patients with and without HIV co-infection. BMC Infect Dis 12: 66.
13. Federal Ministry of Health (2008) Tuberculosis, Leprosy and TB/HIV Prevention and Control Programme. Fed Minist Heal Ethiop.
14. Andersen AB, Range NS, Changalucha J, Praygod G, Kidola J, et al. (2012) CD4 lymphocyte dynamics in Tanzanian pulmonary tuberculosis patients with and without HIV co-infection. BMC Infect Dis 12: 66.
15. Djomand G, Diaby L, N'Gbichi JM, Coulibaly D, Kadio A, et al. (1994) Idiopathic CD4+ T-lymphocyte depletion in a west African population. AIDS 8: 843-847.
16. Turett GS, Telzak EE (1994) Normalization of CD4+ T-lymphocyte depletion in patients without HIV infection treated for tuberculosis. Chest 105: 1335-1337.
17. Pilheu JA, De Salvo MC, Gonzalez J, Rey D, Elias MC, et al. (1997) CD4+ T-lymphocytopenia in severe pulmonary tuberculosis without evidence of human immunodeficiency virus infection. Int J Tuberc Lung Dis 1: 422-426.
18. Gustafson P, Gomes VF, Vieira CS, Samb B, Nauclér A, et al. (2007) Clinical predictors for death in HIV-positive and HIV-negative tuberculosis patients in Guinea-Bissau. Infection 35: 69-80.
19. Zachariah R, Spielmann MP, Harries AD, Salaniponi FML (n.d.) Moderate to severe malnutrition in patients with tuberculosis is a risk factor associated with early death. Trans R Soc Trop Med Hyg 96: 291-294.
20. Mupere E, Malone L, Zalwango S, Chiunda A, Okwera A, et al. (2012) Lean tissue mass wasting is associated with increased risk of mortality among women with pulmonary tuberculosis in urban Uganda. Ann Epidemiol 22: 466-473.
21. Kim DK, Kim HJ, Kwon S-Y, Yoon H-I, Lee C-T, et al. (2008) Nutritional deficit as a negative prognostic factor in patients with miliary tuberculosis. Eur Respir J 32: 1031-1036.
22. Schaible UE, Kaufmann SHE (2007) Malnutrition and infection: complex mechanisms and global impacts. PLoS Med 4: e115.
23. Hood MLH (2013) A narrative review of recent progress in understanding the relationship between tuberculosis and protein energy malnutrition. Eur J Clin Nutr.
24. Dieli F, Friscia G, Di Sano C, Ivanyi J, Singh M, et al. (1999) Sequestration of T lymphocytes to body fluids in tuberculosis: reversal of anergy following chemotherapy. J Infect Dis 180: 225-228.
25. Guyot-Revol V, Innes JA, Hackforth S, Hinks T, Lalvani A (2006) Regulatory T cells are expanded in blood and disease sites in patients with tuberculosis. Am J Respir Crit Care Med 173: 803-810.
26. De Groote M a, Nahid P, Jarlsberg L, Johnson JL, Weiner M, et al. (2013) Elucidating novel serum biomarkers associated with pulmonary tuberculosis treatment. PLoS One 8: e61002.
27. Villamor E, Saathoff E, Mugusi F, Bosch RJ, Urassa W, et al. (2006) Wasting and body composition of adults with pulmonary tuberculosis in relation to HIV-1 coinfection, socioeconomic status, and severity of tuberculosis. Eur J Clin Nutr 60: 163-171.
28. Cingolani A, Cozzi Lepri A, Castagna A, Goletti D, De Luca A, et al. (2012) Impaired CD4 T-cell count response to combined antiretroviral therapy in antiretroviral-naive HIV-infected patients presenting with tuberculosis as AIDS-defining condition. Clin Infect Dis 54: 853-861.
29. Iwnetu R, van den Hombergh J, Woldeamanuel Y, Asfaw M, Gebrekirstos C, et al. (2009) Is tuberculous lymphadenitis over-diagnosed in Ethiopia? Comparative performance of diagnostic tests for mycobacterial lymphadenitis in a high-burden country. Scand J Infect Dis 41: 462-468.
30. WHO (2004) HIV assays: Operational Characteristics. World Health Organization.